Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology

Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology

LAS VEGAS, NEVADA / ACCESS Newswire / April 29, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial…

Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology - Financial News Media

Las Vegas, NV – April 29, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that The Center for Devices and Radiological Health of the U.S. Food and Drug Administration (FDA) has received the company’s submission package requesting…